Status:
TERMINATED
Caregiver Assessments of the Quality of Home Hospice Care
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The Objectives are to administer the Family Evaluation of Hospice Care (FEHC) questionnaire and The Texas Revised Inventory of Grief (TRIG) to caregivers previously enrolled into the parent grant and ...
Detailed Description
After the death of their loved-ones, caregivers will be asked to report on the care received by their care recipient and the quality of practical and emotional care provided to them by hospice by comp...
Eligibility Criteria
Inclusion
- Bereaved family caregivers who completed their participation in the parent protocol (2006-0494) and have lost their loved one within 3-23 months.
- Caregivers who participated in the parent grant met the inclusion/exclusion criteria of the parent grant.
Exclusion
- Bereaved family caregivers who did not complete their participation in the parent protocol or any other caregiver who was never enrolled in the parent protocol (2006-0494).
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 28 2020
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00895024
Start Date
April 1 2009
End Date
September 28 2020
Last Update
October 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030